670 related articles for article (PubMed ID: 31451501)
21. Quantitative Analysis of Single-Nucleotide Polymorphism for Rapid Detection of TR34/L98H- and TR46/Y121F/T289A-Positive Aspergillus fumigatus Isolates Obtained from Patients in Iran from 2010 to 2014.
Mohammadi F; Hashemi SJ; Zoll J; Melchers WJ; Rafati H; Dehghan P; Rezaie S; Tolooe A; Tamadon Y; van der Lee HA; Verweij PE; Seyedmousavi S
Antimicrob Agents Chemother; 2016 Jan; 60(1):387-92. PubMed ID: 26525787
[TBL] [Abstract][Full Text] [Related]
22. Azole resistance in canine and feline isolates of Aspergillus fumigatus.
Talbot JJ; Kidd SE; Martin P; Beatty JA; Barrs VR
Comp Immunol Microbiol Infect Dis; 2015 Oct; 42():37-41. PubMed ID: 26387063
[TBL] [Abstract][Full Text] [Related]
23. cyp51A-Based mechanisms of Aspergillus fumigatus azole drug resistance present in clinical samples from Germany.
Bader O; Weig M; Reichard U; Lugert R; Kuhns M; Christner M; Held J; Peter S; Schumacher U; Buchheidt D; Tintelnot K; Groß U;
Antimicrob Agents Chemother; 2013 Aug; 57(8):3513-7. PubMed ID: 23669382
[TBL] [Abstract][Full Text] [Related]
24. New Insights into the Cyp51 Contribution to Azole Resistance in
Pérez-Cantero A; López-Fernández L; Guarro J; Capilla J
Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31061160
[TBL] [Abstract][Full Text] [Related]
25. The cdr1B efflux transporter is associated with non-cyp51a-mediated itraconazole resistance in Aspergillus fumigatus.
Fraczek MG; Bromley M; Buied A; Moore CB; Rajendran R; Rautemaa R; Ramage G; Denning DW; Bowyer P
J Antimicrob Chemother; 2013 Jul; 68(7):1486-96. PubMed ID: 23580559
[TBL] [Abstract][Full Text] [Related]
26. Aspergillus fumigatus Clinical Isolates Carrying CYP51A with TR34/L98H/S297T/F495I Substitutions Detected after Four-Year Retrospective Azole Resistance Screening in Brazil.
Pontes L; Beraquet CAG; Arai T; Pigolli GL; Lyra L; Watanabe A; Moretti ML; Schreiber AZ
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31871090
[TBL] [Abstract][Full Text] [Related]
27. In vitro activity of olorofim against Aspergillus fumigatus sensu lato clinical isolates: activity is retained against isolates showing resistance to azoles and/or amphotericin B.
Escribano P; Gómez A; Reigadas E; Muñoz P; Guinea J;
Clin Microbiol Infect; 2022 Sep; 28(9):1291.e7-1291.e10. PubMed ID: 35597509
[TBL] [Abstract][Full Text] [Related]
28. Pesticide behavior in paddy fields and development of azole-resistant Aspergillus fumigatus: Should we be concerned?
Vaezi A; Fakhim H; Javidnia J; Khodavaisy S; Abtahian Z; Vojoodi M; Nourbakhsh F; Badali H
J Mycol Med; 2018 Mar; 28(1):59-64. PubMed ID: 29496370
[TBL] [Abstract][Full Text] [Related]
29. Isolation of multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR/L98H mutations in the cyp51A gene in India.
Chowdhary A; Kathuria S; Randhawa HS; Gaur SN; Klaassen CH; Meis JF
J Antimicrob Chemother; 2012 Feb; 67(2):362-6. PubMed ID: 22028200
[TBL] [Abstract][Full Text] [Related]
30. Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs.
Buil JB; Brüggemann RJM; Wasmann RE; Zoll J; Meis JF; Melchers WJG; Mouton JW; Verweij PE
J Antimicrob Chemother; 2018 Jan; 73(1):134-142. PubMed ID: 29048485
[TBL] [Abstract][Full Text] [Related]
31. Genotype-phenotype complexity of the TR46/Y121F/T289A cyp51A azole resistance mechanism in Aspergillus fumigatus.
Snelders E; Camps SM; Karawajczyk A; Rijs AJ; Zoll J; Verweij PE; Melchers WJ
Fungal Genet Biol; 2015 Sep; 82():129-35. PubMed ID: 26092193
[TBL] [Abstract][Full Text] [Related]
32. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
Sanglard D; Coste AT
Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
[TBL] [Abstract][Full Text] [Related]
33. High prevalence of clinical and environmental triazole-resistant Aspergillus fumigatus in Iran: is it a challenging issue?
Nabili M; Shokohi T; Moazeni M; Khodavaisy S; Aliyali M; Badiee P; Zarrinfar H; Hagen F; Badali H
J Med Microbiol; 2016 Jun; 65(6):468-475. PubMed ID: 27008655
[TBL] [Abstract][Full Text] [Related]
34. Epidemiological cutoffs and cross-resistance to azole drugs in Aspergillus fumigatus.
Rodriguez-Tudela JL; Alcazar-Fuoli L; Mellado E; Alastruey-Izquierdo A; Monzon A; Cuenca-Estrella M
Antimicrob Agents Chemother; 2008 Jul; 52(7):2468-72. PubMed ID: 18474574
[TBL] [Abstract][Full Text] [Related]
35. Drug Sensitivity and Resistance Mechanism in Aspergillus Section
Hashimoto A; Hagiwara D; Watanabe A; Yahiro M; Yikelamu A; Yaguchi T; Kamei K
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28607016
[No Abstract] [Full Text] [Related]
36. Contributions of both ATP-Binding Cassette Transporter and Cyp51A Proteins Are Essential for Azole Resistance in Aspergillus fumigatus.
Paul S; Diekema D; Moye-Rowley WS
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28264842
[TBL] [Abstract][Full Text] [Related]
37. Azole susceptibility in clinical and environmental isolates of Aspergillus fumigatus from eastern Hokkaido, Japan.
Toyotome T; Fujiwara T; Kida H; Matsumoto M; Wada T; Komatsu R
J Infect Chemother; 2016 Sep; 22(9):648-50. PubMed ID: 27050399
[TBL] [Abstract][Full Text] [Related]
38. Exploring azole antifungal drug resistance in Aspergillus fumigatus with special reference to resistance mechanisms.
Chowdhary A; Sharma C; Hagen F; Meis JF
Future Microbiol; 2014; 9(5):697-711. PubMed ID: 24957095
[TBL] [Abstract][Full Text] [Related]
39. Three-dimensional models of 14α-sterol demethylase (Cyp51A) from Aspergillus lentulus and Aspergillus fumigatus: an insight into differences in voriconazole interaction.
Alcazar-Fuoli L; Cuesta I; Rodriguez-Tudela JL; Cuenca-Estrella M; Sanglard D; Mellado E
Int J Antimicrob Agents; 2011 Nov; 38(5):426-34. PubMed ID: 21871783
[TBL] [Abstract][Full Text] [Related]
40. Cryptic species and azole resistance in the Aspergillus niger complex.
Howard SJ; Harrison E; Bowyer P; Varga J; Denning DW
Antimicrob Agents Chemother; 2011 Oct; 55(10):4802-9. PubMed ID: 21768508
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]